Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026)
Johnson & Johnson recorded quarterly Total Current Liabilities of $57.7 billion in Q1 2026, up 6.63% quarter-over-quarter from $54.1 billion in Q4 2025, and up 1.43% year-over-year from $56.9 billion in Q1 2025.
Johnson & Johnson's Total Current Liabilities history runs 18 years deep, the most recent figure standing at $57.7 billion for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 1.43% year-over-year to $57.7 billion; the TTM figure through Mar 2026 stood at $57.7 billion (up 1.43% YoY), while the FY2025 annual figure was $54.1 billion, up 7.56% from the prior year.
- Total Current Liabilities came in at $57.7 billion for Q1 2026 at Johnson & Johnson, up from $54.1 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $60.4 billion in Q2 2023 to a low of $43.4 billion in Q2 2022.
- A 5-year average of $51.0 billion and a median of $51.3 billion in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 39.14% in 2023 and declined 19.29% in 2024, its largest moves.
- Johnson & Johnson's Total Current Liabilities stood at $45.5 billion in 2022, then climbed by 1.62% to $46.3 billion in 2023, then grew by 8.73% to $50.3 billion in 2024, then advanced by 7.56% to $54.1 billion in 2025, then climbed by 6.63% to $57.7 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $57.7 billion, $54.1 billion, and $50.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 36.63 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 57.72 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 42.10 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 26.95 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 24.96 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 9.48 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 34.35 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 19.16 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 28.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 57.72 Bn |
| Dec 28, 2025 | 54.13 Bn |
| Sep 28, 2025 | 50.87 Bn |
| Jun 29, 2025 | 54.18 Bn |
| Mar 30, 2025 | 56.90 Bn |
| Dec 29, 2024 | 50.32 Bn |
| Sep 29, 2024 | 51.76 Bn |
| Jun 30, 2024 | 53.93 Bn |
| Mar 31, 2024 | 48.73 Bn |
| Dec 31, 2023 | 46.28 Bn |
| Oct 1, 2023 | 44.37 Bn |
| Jul 2, 2023 | 54.17 Bn |
| Apr 2, 2023 | 60.37 Bn |
| Jan 1, 2023 | 55.80 Bn |
| Oct 2, 2022 | 45.54 Bn |
| Jul 3, 2022 | 44.82 Bn |
| Apr 3, 2022 | 43.39 Bn |
| Jan 2, 2022 | 45.23 Bn |
| Oct 3, 2021 | 44.56 Bn |
| Jul 4, 2021 | 38.72 Bn |
| Apr 4, 2021 | 40.93 Bn |
| Jan 3, 2021 | 42.49 Bn |
| Sep 27, 2020 | 38.85 Bn |
| Jun 28, 2020 | 36.77 Bn |
| Mar 29, 2020 | 33.69 Bn |
| Dec 29, 2019 | 35.96 Bn |
| Sep 29, 2019 | 35.16 Bn |
| Jun 30, 2019 | 31.35 Bn |
| Mar 31, 2019 | 29.11 Bn |
| Dec 30, 2018 | 31.23 Bn |
| Sep 30, 2018 | 27.44 Bn |
| Jul 1, 2018 | 27.49 Bn |
| Apr 1, 2018 | 27.08 Bn |
| Dec 31, 2017 | 30.54 Bn |
| Oct 1, 2017 | 31.81 Bn |
| Jul 2, 2017 | 28.87 Bn |
| Apr 2, 2017 | 25.12 Bn |
| Jan 1, 2017 | 26.29 Bn |
| Oct 2, 2016 | 23.23 Bn |
| Jul 3, 2016 | 21.54 Bn |
| Apr 3, 2016 | 22.13 Bn |
| Jan 3, 2016 | 27.75 Bn |
| Sep 27, 2015 | 25.26 Bn |
| Jun 28, 2015 | 24.51 Bn |
| Mar 29, 2015 | 23.84 Bn |
| Dec 28, 2014 | 25.03 Bn |
| Sep 28, 2014 | 22.98 Bn |
| Jun 29, 2014 | 24.36 Bn |
| Mar 30, 2014 | 23.84 Bn |
| Dec 29, 2013 | 25.68 Bn |
| Sep 29, 2013 | 25.84 Bn |
| Jun 30, 2013 | 23.77 Bn |
| Mar 31, 2013 | 22.52 Bn |
| Dec 30, 2012 | 24.26 Bn |
| Sep 30, 2012 | 23.94 Bn |
| Jul 1, 2012 | 23.85 Bn |
| Apr 1, 2012 | 21.20 Bn |
| Jan 1, 2012 | 22.81 Bn |
| Oct 2, 2011 | 21.69 Bn |
| Jul 3, 2011 | 20.99 Bn |
| Apr 3, 2011 | 24.01 Bn |
| Jan 2, 2011 | 23.07 Bn |
| Oct 3, 2010 | 17.41 Bn |
| Jul 4, 2010 | 17.16 Bn |
| Apr 4, 2010 | 18.50 Bn |
| Jan 3, 2010 | 21.73 Bn |
| Sep 27, 2009 | 19.25 Bn |
| Jun 28, 2009 | 19.89 Bn |